Indefinite Delivery Contract SPE2DB22D9155
- Not listed
- The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to procure various pharmaceutical products and medical supplies. Task orders issued against the contract called for delivery of items such as vaccines, contraceptives, wound treatment materials, and other medical commodities to locations including Park Ridge, Illinois. Delivery orders ranged from approximately $4 to over $2 million, with periods of performance typically...
- The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to supply pharmaceutical products and medical supplies in support of Department of Defense healthcare programs. Delivery orders issued against the contract procured a range of prescription drugs, vaccines, medical implants and other supplies for distribution to military treatment facilities. Key products delivered included oncology pharmaceuticals, respiratory medications, contraceptives and...
- The Defense Logistics Agency awarded a single-award indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies. The contract has a potential value of $499,999,999 and period of performance through December 31, 2025. Under the contract, DMS Pharmaceutical Group Inc. received ten delivery orders for pharmaceuticals and medical supplies valued between $3-$409 to be delivered to locations in Park Ridge, Illinois by various dates in 2023. The...
- DMS Pharmaceutical Group Inc. has been awarded an indefinite delivery contract by the Defense Logistics Agency to provide pharmaceutical supplies and medical products. The contract has a potential value of up to $5 million and a period of performance through December 2025. Under the contract, DMS Pharmaceutical Group will supply various pharmaceutical items and medical supplies to support military treatment facilities worldwide. Some of the key products to be delivered include atropine,...
- The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. as the prime contractor. The contract functions as a blanket purchase agreement for the Agency to issue delivery orders on an as-needed basis for pharmaceutical products and medical supplies in support of Department of Defense force health protection programs. Delivery orders provided under the contract call for DMS Pharmaceutical to supply various vaccines, contraceptive devices, antibiotics,...
- The Defense Logistics Agency awarded an indefinite-delivery contract to DMS Pharmaceutical Group Inc. to provide various pharmaceutical products and services in support of Department of Defense medical readiness programs. Delivery orders issued against the contract procured medications including oncology drugs, injectables, implants, and other pharmaceutical items for delivery to locations in Park Ridge, Illinois with performance periods ranging from one day to one month. The total potential...
- The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to fulfill pharmaceutical and medical supply requirements. The contract utilizes single award task orders placed against the award to procure various prescription drugs, medical devices, and related products. Task orders described delivery of medications including cancer treatments, cystic fibrosis drugs, contraceptives, antibiotics, and other prescribed therapeutics to locations in Park...
- The Defense Logistics Agency awarded an indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of DLA and Department of Defense operations. Over the period of performance from April 2022 through December 2025, DMS Pharmaceutical Group Inc. serves as the prime contractor fulfilling delivery orders against the contract for items including botulinum toxin, contraceptive implants, vaccines, intrauterine...
- The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies. The single award contract utilizes firm fixed price and delivery order pricing mechanisms. Task orders issued against the contract include delivery of pharmaceuticals such as vaccines, cancer treatments, and respiratory medications. Orders require delivery of products such as YF-VAX, Keytruda, Xolair, and Actemra to locations in Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, holds a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Medical Supply Chain division valued at $44.2 million with an ultimate completion date of March 25, 2031. This contract, awarded on March 25, 2021, with no set-aside designation, authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of...
- SPE2DB22D9155Indefinite Delivery Contract
- 13Federal Contract Awards
The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to supply various pharmaceutical products. Delivery orders issued against the contract procured atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolam hydrochloride, and other medical supplies for a total value of approximately $5,000. Performance occurred at the prime contractor's location in Park Ridge, Illinois with completion dates ranging from March 2023 to December 2025. No set-aside provisions were applied to the contract or associated delivery orders. The purpose of the award is to support the Defense Logistics Agency's mission of managing the Department of Defense's medical supply chain by providing critical pharmaceuticals and other medical products to military treatment facilities and partners worldwide. The contract utilizes the indefinite delivery contract vehicle to establish DMS Pharmaceutical Group Inc. as a supplier for the Defense Logistics Agency's pharmaceutical needs. Delivery orders issued against the contract procure specific medical supplies on a firm fixed price basis and within defined period of performance windows. The award aims to fulfill requirements for pharmaceuticals and medical products needed to support the healthcare of military personnel under the Defense Logistics Agency's purview.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/28/22 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DB22D9155-SPE2DB23FSHY1 | DMS Pharmaceutical Group Inc. | $65 | 3/10/23 | 3/13/23 | 3/10/23 | |
Delivery Order SPE2DB22D9155-SPE2DB25FSHY4 | DMS Pharmaceutical Group Inc. | $1.6k | 4/4/25 | 4/7/25 | 4/4/25 | |
Delivery Order SPE2DB22D9155-SPE2DB23FSHY4 | DMS Pharmaceutical Group Inc. | $910 | 7/11/23 | 7/12/23 | 7/11/23 | |
Delivery Order SPE2DB22D9155-SPE2DB25FSHY7 | DMS Pharmaceutical Group Inc. | $390 | 9/2/25 | 9/3/25 | 9/2/25 | |
Delivery Order SPE2DB22D9155-SPE2DB23FSHY2 | DMS Pharmaceutical Group Inc. | $51 | 3/14/23 | 3/15/23 | 3/14/23 |